Three Things to Know About FDA’s “Plausible Mechanism” Guidance

On February 23, 2026, the U.S. Food & Drug Administration (FDA) published a press announcement regarding a new draft guidance titled “Considerations for the Use of the Plausible Mechanism Framework to Develop Individualized Therapies that Target Specific Genetic Conditions with Known Biological Cause.”... By: MoFo Life Sciences